InvestorsHub Logo
Followers 827
Posts 119484
Boards Moderated 15
Alias Born 09/05/2002

Re: None

Monday, 04/22/2019 10:21:09 AM

Monday, April 22, 2019 10:21:09 AM

Post# of 866
FDA approves Ketyruda/Inlyta in 1L-RCC:

https://finance.yahoo.com/news/fda-approves-merck-keytruda-pembrolizumab-104500869.html

The RCC marketplace battle lines are set: Opdivo/Yervoy vs Keytruda/Inlyta.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRK News